SenesTech, Inc.
Company Stats
- Market Cap
- $3.7M
- as of Sep 30, 2026
- Shares Outstanding
- 5.4M
- Free Float
- 27.8%
Income Statement
- Revenue
- $2.2M
- Operating Income
- -$6.5M
- Net Income
- -$6.4M
- EBITDA
- -$6.4M
- Revenue Growth, 3Y
- 29.7%
- FCF Margin, 3Y Avg
- -413.7%
- FCF Margin, Worst Year
- -646.7%
Cash Flow
- Free Cash Flow
- -$5.9M
- FCF Yield
- -160.4%
- Owner FCF Yield
- -167.6%
Balance Sheet
- Cash & Equivalents
- $7.6M
Returns & Capital
- SBC, 3Y Avg
- $381,667
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.2M | -$5.9M | -265.1% |
| FY2024 | $1.9M | -$6.1M | -329.4% |
| FY2023 | $1.2M | -$7.7M | -646.7% |
| FY2022 | $1.0M | -$8.8M | -858.8% |
| FY2021 | $600,000 | -$7.9M | -1313.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
XBiotech Leads Buying Intensity; Gold.com Draws $3.93 Million